Wyndly
PrivateLast Round
Series A
Feb 8, 2023
Est. Valuation
$1.79M
Total Funding Raised
$2.13M
Company Overview
Wyndly operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in February 2023.
Wyndly is a telehealth company that provides personalized, at-home treatment for allergies. The company offers sublingual immunotherapy (allergy drops) intended to provide long-term relief by retraining the body's immune system to ignore allergy triggers. Wyndly combines the convenience of direct-to-consumer telehealth with personalized care from board-certified doctors, shipping allergy tests and treatments directly to patients' doors. Founded in 2020 and a participant in the Y Combinator (W21) batch, the company aims to modernize allergy care and make it more accessible. It has raised $2.12 million in funding from investors including Y Combinator and Goodwater Capital.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Precision Medicine, Subscription Commerce, D2C Brands
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wyndly Comparables
Compare Wyndly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nectar Life Sciences | 93% | |
| Curex | 93% | |
| HeyAllergy | 89% |
For institutional investors. Book with your work email.
Wyndly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 8, 2023 | ||||
| Seed | Feb 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wyndly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Goodwater Capital | Series A |
| Y Combinator | Seed, Series A |
| Sweater Ventures | Series A |
| Civilization Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
Added Sollis Health FL, Inc. as a customer.
- Oct 7, 2025
Added Judge.me Ltd, a SaaS company, as a customer.
For institutional investors. Book with your work email.
Wyndly Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wyndly's valuation, stock price, and market status.
Is Wyndly a public or private company?
Wyndly is a private company.
What is the current stock price of Wyndly?
Wyndly is a private company, so its shares have no public market price. Caplight tracks Wyndly's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wyndly worth (valuation)?
Wyndly's valuation is estimated at $1.8M based on funding round data.
Can I buy Wyndly stock?
Wyndly shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wyndly's last funding round?
Wyndly's most recent funding round was Series A on February 8, 2023.
Who are the main investors in Wyndly?
Key investors in Wyndly include Goodwater Capital, Y Combinator, Sweater Ventures, Civilization Ventures.
Will Wyndly IPO soon?
No public IPO plans have been announced for Wyndly.
How can I track Wyndly secondary market activity?
Caplight tracks bids, offers, and trades in Wyndly's shares on secondary markets.